In Alzheimer’s disease, nicotine improves cognitive impairment by increasing the activity of protein kinase B (also known as Akt) and stimulating phosphoinositide 3-kinase/Akt signaling, which regulates learning and memory processes [78]. Here, AKT1 is linked to early-onset autosomal dominant Alzheimer disease.